KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Zoetis (ZTS) over the last 16 years, with Q3 2025 value amounting to $410.0 million.

  • Zoetis' Accounts Payables rose 148.51% to $410.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $410.0 million, marking a year-over-year increase of 148.51%. This contributed to the annual value of $433.0 million for FY2024, which is 535.28% up from last year.
  • Per Zoetis' latest filing, its Accounts Payables stood at $410.0 million for Q3 2025, which was up 148.51% from $508.0 million recorded in Q2 2025.
  • Zoetis' 5-year Accounts Payables high stood at $508.0 million for Q2 2025, and its period low was $346.0 million during Q1 2021.
  • Its 5-year average for Accounts Payables is $412.4 million, with a median of $410.0 million in 2025.
  • In the last 5 years, Zoetis' Accounts Payables skyrocketed by 3056.6% in 2021 and then crashed by 948.28% in 2024.
  • Over the past 5 years, Zoetis' Accounts Payables (Quarter) stood at $436.0 million in 2021, then fell by 7.11% to $405.0 million in 2022, then grew by 1.48% to $411.0 million in 2023, then increased by 5.35% to $433.0 million in 2024, then decreased by 5.31% to $410.0 million in 2025.
  • Its Accounts Payables stands at $410.0 million for Q3 2025, versus $508.0 million for Q2 2025 and $420.0 million for Q1 2025.